Skip to main content
. 2020 May 6;10:7683. doi: 10.1038/s41598-020-64732-8

Table 2.

Demographic and disease characteristics of the 769 patients.

RA OA SLE axSPA pSpA p
N (%) 307 (39.9) 213 (27.7) 63 (8.2) 103 (13.4) 83 (10.8)
Age: years (SD) 57.3 (12.8) 63.6 (10.7) 42.8 (13.7) 46.7 (11.6) 51.2 (12.9) <0.001
Female: % 82.1 81.2 93.7 43.7 74.7 <0.001
Smoking: % 28.0 18.3 11.1 28.2 10.80 <0.001
Alcohol: % 1.6 4.8 3.8 8.2 2.2 0.562
BMI kg/m2 (SD) 27.1 27.0 25.6 26.8 27.9 0.065
Profession: active (%) 39.5 26.1 48.7 79.5 53.1 <0.001
Disease duration, months 103.5 84.5 93.5 94.2 82.6 0.013
Conventional DMARDs: % 70.4 n/a 72.2 54.2 72.2 0.196
Biologic DMARDs: % 30.1 n/a n/a 46.8 33.3 0.105
Corticosteroids: % 21.0 2.5 38.9 4.1 15.0 <0.001
NSAIDs (chronic): % 27.2 2.60 24.1 41.1 26.3 <0.001

RA = Rheumatoid Arthritis. OA = Osteoarthritis. SLE = Systemic Lupus Erythematosus, axSpA = Axial Spondyloarthritis. pSpA= Peripheral Spondyloarthritis. BMI: Body Mass Index. DMARDs: Disease-Modifying Anti-Rheumatic Drugs. NSAIDs: Non-Steroidal Anti-Inflammatory Drugs. DAS-28: Disease Activity Score. ESR: Erythrocyte Sedimentation Rate. n/a = not applicable.